GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $256,000 | -12.0% | 5,837 | -11.4% | 0.02% | +4.8% |
| Q1 2022 | $291,000 | +12.8% | 6,587 | +13.8% | 0.02% | +10.5% |
| Q4 2021 | $258,000 | +24.0% | 5,787 | +8.0% | 0.02% | +18.8% |
| Q3 2021 | $208,000 | -2.3% | 5,358 | 0.0% | 0.02% | -15.8% |
| Q2 2021 | $213,000 | +5.4% | 5,358 | 0.0% | 0.02% | -24.0% |
| Q3 2020 | $202,000 | -5.6% | 5,358 | +1.9% | 0.02% | -13.8% |
| Q2 2020 | $214,000 | +3.4% | 5,258 | -3.7% | 0.03% | -14.7% |
| Q1 2020 | $207,000 | -19.1% | 5,458 | 0.0% | 0.03% | +6.2% |
| Q4 2019 | $256,000 | +14.3% | 5,458 | +3.8% | 0.03% | +6.7% |
| Q3 2019 | $224,000 | +6.7% | 5,258 | 0.0% | 0.03% | +3.4% |
| Q2 2019 | $210,000 | -53.3% | 5,258 | -51.2% | 0.03% | -6.5% |
| Q1 2019 | $450,000 | +118.4% | 10,766 | +100.0% | 0.03% | -8.8% |
| Q4 2018 | $206,000 | -4.6% | 5,383 | 0.0% | 0.03% | +13.3% |
| Q3 2018 | $216,000 | -0.5% | 5,383 | 0.0% | 0.03% | -6.2% |
| Q2 2018 | $217,000 | -13.5% | 5,383 | -16.3% | 0.03% | -13.5% |
| Q1 2018 | $251,000 | +10.1% | 6,433 | 0.0% | 0.04% | +12.1% |
| Q4 2017 | $228,000 | -18.9% | 6,433 | -7.2% | 0.03% | -23.3% |
| Q3 2017 | $281,000 | -6.0% | 6,933 | 0.0% | 0.04% | -8.5% |
| Q2 2017 | $299,000 | -22.3% | 6,933 | -24.0% | 0.05% | -23.0% |
| Q1 2017 | $385,000 | +26.6% | 9,121 | +15.7% | 0.06% | +19.6% |
| Q4 2016 | $304,000 | -10.6% | 7,883 | 0.0% | 0.05% | -13.6% |
| Q3 2016 | $340,000 | -1.7% | 7,883 | -1.3% | 0.06% | -1.7% |
| Q2 2016 | $346,000 | -54.5% | 7,983 | -57.5% | 0.06% | -54.2% |
| Q1 2016 | $761,000 | -0.1% | 18,777 | -0.5% | 0.13% | +0.8% |
| Q4 2015 | $762,000 | +3.0% | 18,877 | -1.9% | 0.13% | +0.8% |
| Q3 2015 | $740,000 | -8.4% | 19,242 | -0.8% | 0.13% | -0.8% |
| Q2 2015 | $808,000 | -9.5% | 19,396 | +0.2% | 0.13% | -7.8% |
| Q1 2015 | $893,000 | +7.6% | 19,359 | -0.4% | 0.14% | +6.8% |
| Q4 2014 | $830,000 | -5.6% | 19,430 | +1.6% | 0.13% | -5.7% |
| Q3 2014 | $879,000 | -17.9% | 19,130 | -4.4% | 0.14% | -18.1% |
| Q2 2014 | $1,070,000 | -0.5% | 20,005 | -0.5% | 0.17% | -4.5% |
| Q1 2014 | $1,075,000 | -0.4% | 20,115 | -0.5% | 0.18% | +0.6% |
| Q4 2013 | $1,079,000 | +6.4% | 20,215 | 0.0% | 0.18% | -3.3% |
| Q3 2013 | $1,014,000 | +0.8% | 20,215 | +0.4% | 0.18% | -1.6% |
| Q2 2013 | $1,006,000 | – | 20,140 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |